SYDNIE NICKELL: Open Payments
NPI 1184377095 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 15 payments from 11 companies in 2025. Trend: 2023 $410 · 2024 $493 · 2025 $481
Food & beverage: $301Education: $180
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 1 | $100 |
| Astellas Pharma US Inc | 1 | $80 |
| ABBVIE INC. | 3 | $65 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| SpringWorks Therapeutics, Inc. | 2 | $43 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Tempus AI, Inc | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Iovance Biotherapeutics, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $21 |
Products named: Enhertu, EPKINLY, GOMEKLI, LYNPARZA, KISQALI, SCEMBLIX, XT CDX, OJJAARA.
Industry payments across TN — which companies pay providers there.
